PrimeRFP SCOUT · Federal Contract Recompete Brief

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO…

Contract75N91020F00025

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO… is a federal award for Department of Health and Human Services (HHS) held by LEIDOS BIOMEDICAL RESEARCH, INC.. Estimated value $97.5M ($85.1M obligated). Current period of performance ends Sep 24, 2028. Place of performance: FREDERICK, MD.

$97.5M
Estimated Value
$85.1M
Obligated
Sep 24, 2028
PoP End / Expires
More in SCOUT — score this to your firm →See related expiring contracts →
AnalysisPublic

LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the Sep 24, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract factsFederal
Contract number75N91020F00025
AgencyDepartment of Health and Human Services (HHS)
IncumbentLEIDOS BIOMEDICAL RESEARCH, INC.
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
PoP end (current)Sep 24, 2028
Obligated$85.1M

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR

Recompete timingPublic
Expiring in 790 days

Current PoP ends Sep 24, 2028 (790 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 24, 2027.

Track recompete timing in SCOUT →
Incumbent footprintPublic record

LEIDOS BIOMEDICAL RESEARCH, INC.$2.3B obligated across 187 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Open full company profile
Related awardsSame parent · incumbent
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$81.1M
Aug 31, 2026
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91019F00139
MD NET
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$163.5M
Sep 29, 2028
75N91020F00039
NIAID COVID-19 ACTIV3
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$281.6M
Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91019D00024-75N91020F00025